成人中线胶质瘤与弥漫性中线胶质瘤的生存分析:超越H3K27突变范式
本研究回顾性分析2010至2020年间124例成人中线胶质瘤,其中44例(35.5%)存在H3K27改变。多变量Cox回归校正年龄、体能状态和治疗方式后,H3K27改变对总生存无独立负面影响(HR 1.014,p=0.956)。在44例弥漫性中线胶质瘤中,低级别/间变性组织学分级、KPS≥80、全切除和同步放化疗与更好生存相关。
要点
- 成人中线胶质瘤H3K27改变组中位生存23.1个月,野生型15.9个月(p=0.040)。
- 校正混杂因素后H3K27改变并非独立预后不良因素(HR 1.014,p=0.956)。
- 成人弥漫性中线胶质瘤生存受组织学分级、KPS、切除程度和辅助治疗影响。
核心结论
- 与儿童不同,成人H3K27改变的中线胶质瘤在充分校正临床混杂因素后并不固有地预示不良预后。
- 成人WHO 4级弥漫性中线胶质瘤的生存轨迹主要由其潜在形态学侵袭性决定,并与KPS、肿瘤切除范围和辅助治疗策略共同作用。
研究设计与样本
- 回顾性队列研究,纳入2010至2020年间在本机构接受切除或活检的成人中线胶质瘤患者124例。
- 采用Gehan-Breslow-Wilcoxon检验进行单因素生存分析,Cox比例风险回归模型进行多因素生存分析。
- 首次根据组织学分级研究成人弥漫性中线胶质瘤预后,也是研究成人弥漫性中线胶质瘤生存的最大样本研究。
主要发现
- 124例成人中线胶质瘤中44例(35.5%)存在H3K27改变。
- 所有年龄患者中,H3K27改变组中位生存显著优于野生型组(23.1 vs. 15.9个月,p=0.040)。
- 在所有成人患者中,校正年龄、体能状态和治疗方式的多变量Cox回归分析显示,H3K27改变对总生存无统计学显著的独立负面影响(HR 1.014,p=0.956)。
- 44例弥漫性中线胶质瘤的生存分析中,低级别和间变性组织学分级、KPS≥80、全切除和同步放化疗与显著更好的生存相关。
关键数值与推荐
- H3K27改变组与野生型组中位生存分别为23.1个月和15.9个月(p=0.040)。
- 多变量Cox回归中H3K27改变的HR为1.014(p=0.956)。
- 弥漫性中线胶质瘤中与更好生存相关的因素:低级别/间变性组织学分级、KPS≥80、全切除、同步放化疗。
临床怎么用
- 成人中线胶质瘤评估H3K27状态时,应结合组织学分级、KPS、切除程度和治疗策略综合判断预后。
- 对于成人弥漫性中线胶质瘤,争取全切除、维持KPS≥80并采用同步放化疗可能改善生存。
局限性
- 单中心回顾性研究,样本量有限(124例中线胶质瘤,其中44例弥漫性中线胶质瘤)。
- 未报告前瞻性验证或外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although pediatric midline-located gliomas (MGs) with H3K27 alteration have been widely known to have a poor prognosis, few researchers have assessed adult MGs with H3K27 alteration. We aimed to determine the effect of H3K27 alteration on the prognosis of adult MGs. And we tried to identify the factors affecting the prognosis of diffuse midline glioma (DMG). This is the first study to investigate the prognosis of adult DMGs according to histological grade and is the largest study to investigate the survival of adult patients with DMGs. METHODS: We reviewed the charts of adult patients diagnosed with MG after undergoing resection or biopsy at our institution between 2010 and 2020. The Gehan-Breslow-Wilcoxon test was used for univariate survival analysis, and the Cox regression proportional hazard model was used for multivariate survival analysis. RESULTS: Among the 124 adult MGs identified, 44 (35.5%) showed H3K27 alterations. Surprisingly, the H3K27 alteration group showed significantly better median survival than the wildtype group in patients of all ages (23.1 vs. 15.9 months, p = 0.040). Crucially, in the rigorous multivariable Cox regression analysis adjusting for age, performance status, and therapeutic modalities across all adult patients, the H3K27 alteration did not demonstrate a statistically significant independent negative effect on overall survival (HR 1.014, p = 0.956). In the survival analysis of 44 patients with DMG, low and intermittent histological grade, KPS ≥ 80, total resection, and concurrent chemoradiation therapy were associated with significantly better survival. CONCLUSION: Unlike their pediatric counterparts, adult MGs with H3K27 alterations do not inherently confer a poor prognosis when adequately adjusted for clinical confounders. In adults, the survival trajectory of WHO grade 4 DMGs is profoundly dictated by their underlying morphological aggressiveness, functioning alongside KPS, extent of tumor resection, and adjuvant treatment strategies.
引用
- Jung IH, Yoo J, Choi S, et al. Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigm. J Neurooncol. 2026. PMID: 42174302. doi:10.1007/s11060-026-05625-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。